세계의 헬스케어 데이터 수익화 시장 규모, 점유율, 동향 분석 보고서 : 방법별, 조직 규모별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Data Monetization In Healthcare Market Summary

The global data monetization in healthcare market size was estimated at USD 571.6 million in 2024 and is projected to reach USD 3,393.8 million by 2033, growing at a CAGR of 22.3% from 2025 to 2033. The growth is attributed to the increasing adoption of electronic health records (EHRs) and rising public & private investments in advanced analytics solutions.

The data monetization in healthcare industry is experiencing significant growth, driven by increasing awareness of its benefits and a growing focus among healthcare enterprises on robust data management strategies. In addition, the adoption of emerging technologies such as Blockchain, Machine Learning (ML), Artificial Intelligence (AI), cloud computing, and big data analytics is further propelling this trend. Moreover, data monetization software and services enable pharmaceutical, healthcare, and medical technology companies to extract actionable insights, thereby accelerating business growth. Furthermore, these tools enhance operational efficiency by enabling risk prediction and anomaly detection, supporting the expansion of data monetization in healthcare landscape.

The data monetization in healthcare industry is undergoing rapid transformation, fueled by the convergence of advanced analytics platforms and intelligent automation that enable organizations to extract, manage, and monetize data with greater precision and autonomy. A key trend shaping this evolution is the shift toward agentic AI and autonomous data ecosystems that empower healthcare providers, payers, and life sciences firms to unlock latent value from vast datasets, while ensuring compliance, security, and contextual intelligence. These platforms integrate seamlessly with existing data infrastructures, enabling real-time insights generation, anomaly detection, predictive modeling, and revenue optimization.

For instance, in May 2025, Brillio launched ADAM, a pioneering agentic AI platform designed to drive intelligent data autonomy across enterprises. This system facilitates advanced healthcare data monetization by empowering users to automate the end-to-end data lifecycle from acquisition and contextualization to insight extraction and monetization without constant human oversight. By harnessing generative AI, cognitive agents, and adaptive orchestration, ADAM enables healthcare stakeholders to turn fragmented data silos into actionable, revenue-generating assets. Consequently, this reflects a market shift where AI-powered data platforms are not just supporting healthcare analytics but transforming them into core engines of business growth, operational efficiency, and competitive differentiation.

Global Data Monetization In Healthcare Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global data monetization in healthcare market report based on method, organization size, end use, and region:

• Method Outlook (Revenue, USD Million, 2021 - 2033)
• Data As A Service
• Insight As A Service
• Analytics-enabled Platform As A Service
• Embedded Analytics
• Organization Size Outlook (Revenue, USD Million, 2021 - 2033)
• Large Enterprises
• SMEs
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Pharmaceutical & Biotechnology Companies
• Healthcare Players
• Medical Technology Companies
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Methodology segmentation & scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Organization Size

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Data Monetization in Healthcare Variables, Trends & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
  • 3.3.2. Market Restraints Analysis
  • 3.3.3. Industry Opportunities
• 3.4. Data Monetization in Healthcare Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Data Monetization in Healthcare Market: Method Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Data Monetization in Healthcare: Method Movement Analysis, USD Million, 2024 & 2033
• 4.3. Data as a service
  • 4.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Insight as a service
  • 4.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Analytics-enabled platform as a service
  • 4.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.6. Embedded analytics
  • 4.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Data Monetization in Healthcare Market: Organization Size Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Data Monetization in Healthcare: Organization Size Movement Analysis, USD Million, 2024 & 2033
• 5.3. Large Enterprises
  • 5.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.4. SMEs
  • 5.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Data Monetization in Healthcare Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Data Monetization in Healthcare: End Use Movement Analysis, USD Million, 2024 & 2033
• 6.3. Pharmaceutical and Biotechnology Companies
  • 6.3.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Healthcare Players
  • 6.4.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Medical Technology Companies
  • 6.5.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Market Size Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Data Monetization in Healthcare Market: Regional Estimates & Trend Analysis

• 7.1. Data Monetization in Healthcare Share, By Region, 2024 & 2033, USD Million
• 7.2. North America
  • 7.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.2.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
  • 7.2.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
  • 7.2.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.2.5. U.S.
    • 7.2.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.2.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.2.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.2.6. Canada
    • 7.2.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.2.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.2.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.2.7. Mexico
    • 7.2.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.2.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.2.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.2.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
• 7.3. Europe
  • 7.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
  • 7.3.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
  • 7.3.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.3.5. UK
    • 7.3.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.3.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.3.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.3.6. Germany
    • 7.3.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.3.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.3.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.3.7. France
    • 7.3.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.3.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.3.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
  • 7.4.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
  • 7.4.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4.5. China
    • 7.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4.6. India
    • 7.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4.7. Japan
    • 7.4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4.8. Australia
    • 7.4.8.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.8.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.8.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.4.9. South Korea
    • 7.4.9.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.4.9.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.4.9.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
• 7.5. Latin America
  • 7.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
  • 7.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
  • 7.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.5.5. Brazil
    • 7.5.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.5.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.5.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
• 7.6. Middle East & Africa
  • 7.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
  • 7.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
  • 7.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.6.5. Saudi Arabia
    • 7.6.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.6.5.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.6.5.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.6.6. UAE
    • 7.6.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.6.6.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.6.6.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)
  • 7.6.7. South Africa
    • 7.6.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7.2. Market estimates and forecast by Method, 2021 - 2033 (Revenue, USD Million)
    • 7.6.7.3. Market estimates and forecast by Organization Size, 2021 - 2033 (Revenue, USD Million)
    • 7.6.7.4. Market estimates and forecast by End Use, 2021 - 2033 (Revenue, USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2024
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
• 8.6. Company Profiles
  • 8.6.1. Optum, Inc.
    • 8.6.1.1. Participant's Overview
    • 8.6.1.2. Financial Performance
    • 8.6.1.3. Product Benchmarking
    • 8.6.1.4. Recent Developments
  • 8.6.2. Oracle Corporation
    • 8.6.2.1. Participant's Overview
    • 8.6.2.2. Financial Performance
    • 8.6.2.3. Product Benchmarking
    • 8.6.2.4. Recent Developments
  • 8.6.3. SAS Institute Inc.
    • 8.6.3.1. Participant's Overview
    • 8.6.3.2. Financial Performance
    • 8.6.3.3. Product Benchmarking
    • 8.6.3.4. Recent Developments
  • 8.6.4. IBM Corporation
    • 8.6.4.1. Participant's Overview
    • 8.6.4.2. Financial Performance
    • 8.6.4.3. Product Benchmarking
    • 8.6.4.4. Recent Developments
  • 8.6.5. Microsoft Corporation
    • 8.6.5.1. Participant's Overview
    • 8.6.5.2. Financial Performance
    • 8.6.5.3. Product Benchmarking
    • 8.6.5.4. Recent Developments
  • 8.6.6. Google LLC
    • 8.6.6.1. Participant's Overview
    • 8.6.6.2. Financial Performance
    • 8.6.6.3. Product Benchmarking
    • 8.6.6.4. Recent Developments
  • 8.6.7. Snowflake Inc.
    • 8.6.7.1. Participant's Overview
    • 8.6.7.2. Financial Performance
    • 8.6.7.3. Product Benchmarking
    • 8.6.7.4. Recent Developments
  • 8.6.8. IQVIA Inc.
    • 8.6.8.1. Participant's Overview
    • 8.6.8.2. Financial Performance
    • 8.6.8.3. Product Benchmarking
    • 8.6.8.4. Recent Developments
  • 8.6.9. Flatiron Health, Inc.
    • 8.6.9.1. Participant's Overview
    • 8.6.9.2. Financial Performance
    • 8.6.9.3. Product Benchmarking
    • 8.6.9.4. Recent Developments
  • 8.6.10. Palantir Technologies Inc.
    • 8.6.10.1. Participant's Overview
    • 8.6.10.2. Financial Performance
    • 8.6.10.3. Product Benchmarking
    • 8.6.10.4. Recent Developments
  • 8.6.11. Truveta, Inc.
    • 8.6.11.1. Participant's Overview
    • 8.6.11.2. Financial Performance
    • 8.6.11.3. Product Benchmarking
    • 8.6.11.4. Recent Developments
  • 8.6.12. Arcadia Solutions LLC
    • 8.6.12.1. Participant's Overview
    • 8.6.12.2. Financial Performance
    • 8.6.12.3. Product Benchmarking
    • 8.6.12.4. Recent Developments
  • 8.6.13. Clarify Health Solutions, Inc.
    • 8.6.13.1. Participant's Overview
    • 8.6.13.2. Financial Performance
    • 8.6.13.3. Product Benchmarking
    • 8.6.13.4. Recent Developments
  • 8.6.14. Health Catalyst, Inc.
    • 8.6.14.1. Participant's Overview
    • 8.6.14.2. Financial Performance
    • 8.6.14.3. Product Benchmarking
    • 8.6.14.4. Recent Developments